From October 8 to 10, Qingdao Sunrise Health Biotechnology Co., Ltd. debuted at CPHI Milan 2024, a pharmaceutical raw materials exhibition held in Milan, Italy. As an innovation pioneer in the field of health products in China, Goodhealth has attracted the attention of industry experts, partners and visitors from all over the world with its high-quality products and excellent technical strength.

"

Highlights from CPHI Milan 2024

The products of Sunrise at this exhibition cover a variety of nutritional supplements such as tablets, soft capsules, hard capsules and powders, which have attracted the attention of global customers. With many years of innovation and strict quality standards, the company has been highly recognized by exhibitors from Europe, North America, Asia and other places.

During the exhibition, Sunrise conducted in-depth exchanges with a number of internationally renowned enterprises to explore cooperation opportunities in the international market. The high-quality health products brought by the company, relying on the advanced production equipment certified by GMP and strict quality management system, have a unique competitive advantage in the global health market. This is not only a reflection of the company's own strength, but also an important step for China's health industry to move towards the world.

For the first time in CPHI Milan, Sunrise gains not only recognition from global customers, but also an opportunity for self-breakthrough and growth. In the future, the company will continue to actively integrate into the global market with an open attitude, repay every customer with better quality products and services, and contribute China's strength to promote the progress of the global health industry.